Abstract:Objective To investigate the expressions of CD133 and CD44 protein in primary lesions of gastric cancer and its clinical significance. Methods The expressions of CD44 and CD133 protein in gastric cancer tissues of100 patients with gastric cancer were detected by immunohistocheimcal stainings. The relation between the expressions of CD44 and CD133 protein and the clinicopathologic characters were analyzed. Results Both CD44 and CD133protein were expressed on the cell membranes. No correlation were found between CD44/CD133 and the clinicopathologic parameters include gender and age(P0.05), but the positive expression rate of CD44/CD133 with diameter5 cm was significantly higher than that tumor with diameter ≤5 cm(CD44 P=0.150;CD133 P=0.056), and correlated with the tissue differentiation(CD44 P=0.008;CD133 P=0.007), vascular invasion(CD44 P=0.043;CD133 P=0.023), lymphatic vessel invasion(CD44 P=0.020;CD133 P=0.044), lymph nodes metastasis(CD44 P=0.002;CD133 P=0.004), invasion depth of tumor(CD44 P=0.006;CD133 P=0.021), and pTNM stage(CD44 P=0.034;CD133 P=0.001). No correlation were found between the co-expression of CD44 and CD133 protein and the clinicopathologic parameters include gender, age, tissue differentiation, and vascular invasion(P0.05), but the positive co-expression rate of CD44 and CD133 with diameter 5 cm was significantly higher than that tumor with diameter ≤5 cm(P=0.010), and correlated with lymphatic vessel invasion(P=0.003), lymph nodes metastasis(P=0.045), invasion depth of tumor(P=0.041), and pTNM stage(P=0.049). The Spearman rank correlation analysis showed that there was positive correlation between the expressions of CD44 and CD133 protein(r =0.207, P=0.039). Univariate analysis showed that lymph nodes metastasis(P0.001), pTNM stages(P=0.013), CD44 protein expression(P=0.005), CD133 protein expression(P=0.002), and co-expression of CD44 and CD133 protein(P0.001) were significantly correlated with 3-year survival rate of patients with gastric cancer respectively. Logistic regression analysis revealed that lymph node metastasis(P=0.038) was independent risk factor for co-expression of CD44 and CD133 protein. Multivariate analysis with the Cox regression models showed that co-expression of CD44 and CD133 protein(P=0.003) and lymph node metastasis(P=0.006) were significantly associated with poor prognosis. Conclusions CD44 and CD133 protein may be considered as robust cancer stem cell markers in gastric cancer. The co-expression of CD44 and CD133 protein is the independent prognosis factor for gastric cancer and strongly associated with poor prognosis when they are expressed more high.

Expression and Significance of CD44 in Pancreatic Head Cancer

Expression and Significance of CD44 and P-Akt in Pancreatic Head Cancer

CD44 Expression is Predictive of Poor Prognosis in Pharyngolaryngeal Cancer: Systematic Review and Meta-Analysis

Expression of CD44 and Its Clinical Significance in Breast Cancer Tissues

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients

Expression of CD44v6 in Pancreatic Carcinoma and Its Clinical Significance

The prognostic value and immunological role of CD44 in pan-cancer study

Down-expression of CD36 in Pancreatic Adenocarcinoma and Its Correlation with Clinicopathological Features and Prognosis.

Overexpressions of DLL4 and CD105 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

Expression of CD44v5 in Gastric Cancer:Relationships with Lymph Node Metastasis

[Expression and Clinical Significance of Adhesive Molecule CD44v6 in Breast Invasive Ductal Carcinoma].

CD44s expression study in colorectal cancer tissues

Expressions of CD133 and CD44 Protein in Primary Lesion of Gastric Cancer and Its Clinical Significance

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

[Quantitative Studies on Expression of Peripheral Blood CD44 and CD54 in Non-Small Cell Lung Carcinoma].

A study on the relationship between CD44v6 expression and biological characteristics in breast cancer

Expression and Significance of P53 and Bcl-2 Protein Pancreatic Adenocarcinoma

Clinical Signification on CD44 Express of Peripheral Blood Cells in Pat ients with Primary Hepatic Carcinoma

Prognostic value of CD 44 expression in non-small cell lung cancer : a systematic review

Clinical Significance of CD44 Variants Expression in Colorectal Cancer

Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.